Daniel Balakov Research firm Piper Sandler weighed in on a basket of enterprise software stocks on Friday, noting that it has concerns about the weakening macro background and how it could impact lower growth rates for the sector. “We are proactively lowering growth estimates and PTs across our coverage listContinue Reading
designer491 Cara Therapeutics (NASDAQ:CARA) stock closed 28% higher Thursday after it announced it had hired Piper Sandler as its financial advisor to help it explore strategic options. Cara’s (CARA) board has also approved a cash savings plan for the company, which had around $70M in cash and equivalents as ofContinue Reading
deepblue4you/E+ via Getty Images Piper Sandler initiated coverage on Unum Group (NYSE:UNM) with an Overweight rating on Thursday as analyst John Barnidge points to a number of positive developments. The life and health insurer “has the greatest growth, least reliance on variable investment income and also greatest amount of moats”Continue Reading
Alexander Farnsworth Piper Sandler started off coverage on Walmart (NYSE:WMT) with an Overweight rating. The firm thinks the strong year-to-date rally still has legs to run further. “We believe the company is in the early stages of an unprecedented profit growth acceleration for a large and mature retailer,” noted analystContinue Reading
tadamichi Piper Sandler analysts named the stocks that had the biggest upside, measured in standard deviations, in their Portfolio Strategy report. Overall, the S&P 500 (SP500) is now up 14.5% year-to-date. This outperformance during the first half of the year is one of the top three in the last 25Continue Reading
vovashevchuk The negative correlation between the U.S. dollar (DXY) and the S&P 500 (SP500) is expected to continue for several months. According to a technical research report by Piper Sandler, the negative correlation between the U.S. dollar (DXY) and the S&P 500 (SP500) has lessened a little during June (downContinue Reading
JHVEPhoto/iStock Editorial via Getty Images Piper Sandler has initiated Cigna International (NYSE:CI) and Humana (NYSE:HUM) with overweight ratings, saying that the former is poised for long-term EPS growth. The firm has a $400 price target for Cigna (18% upside based on June 25 close) and a $392 target for HumanaContinue Reading
traviswolfe The S&P 500 (SP500) should tumble 10% in the summer due to a correction, said Craig Johnson, chief market technician at Piper Sandler. In a market note, he said that investors are failing to notice the red flags in the market, including poor market breadth and declining momentum. TheContinue Reading
